ADA2 beta Antibody - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-86954
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Format
BSA Free
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the C-terminal region of Human ADA2 beta. Peptide sequence: RKENKNLAGSKRGKEDGKDSEFAAIENLPGFELLSDREKVLCSSLNLSPA The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for ADA2 beta Antibody - BSA Free
![Western Blot: ADA2 beta Antibody [NBP2-86954]](https://resources.bio-techne.com/images/products/ADA2-beta-Antibody-Western-Blot-NBP2-86954-img0001.jpg "Western Blot: ADA2 beta Antibody [NBP2-86954]")
Western Blot: ADA2 beta Antibody [NBP2-86954]
Western Blot: ADA2 beta Antibody [NBP2-86954] - Host: Rabbit. Target Name: TADA2B. Sample Type: MCF7 Whole Cell lysates. Antibody Dilution: 1.0ug/mlApplications for ADA2 beta Antibody - BSA Free
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Format
BSA Free
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: ADA2 beta
Alternate Names
ADA2-beta, ADA2-like protein beta, MGC21874, transcriptional adapter 2-beta, transcriptional adaptor 2 (ADA2 homolog, yeast)-beta, transcriptional adaptor 2B
Gene Symbol
TADA2B
Additional ADA2 beta Products
Product Documents for ADA2 beta Antibody - BSA Free
Product Specific Notices for ADA2 beta Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...